Partnership Between Siemens And Exyte For Biotech Facilities


Siemens and Exyte, a provider of planning and execution of biopharmaceutical production plants, agree on a partnership for integrated solutions in the biopharmaceutical industry.

Siemens and Exyte will jointly offer biotechnology manufacturers and producers of cell and gene therapy standardized turnkey solutions that are compatible with cGMP (current Good Manufacturing Practice) and GAMP (Good Automated Manufacturing Practice).



Go back